SU 23397
Code | Size | Price |
---|
TAR-T34731-5mg | 5mg | £930.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34731-50mg | 50mg | £1,821.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34731-100mg | 100mg | £2,319.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
SU 23397 is a structurally unique neuroleptic agent.
CAS:
37603-15-9
Formula:
C23H27N3O3
Molecular Weight:
393.487
Purity:
0.98
SMILES:
COc1ccc2OC(CN3CCC4(CC3)N(CNC4=O)c3ccccc3)Cc2c1
References
Liebman J, Neale R. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacology (Berl). 1980;68(1):25-9. PubMed PMID: 6104837.
Mielke EH, Gallant DM, Bishop G, Kessler CM. Assessment of antipsychotic activity of an unique agent: SU-23397. Psychopharmacol Commun. 1975;1(2):117-22. PubMed PMID: 4858.
Chaudhuri NK, Ball TJ, Finch N. The absolute configuration of SU 23397: a novel neuroleptic agent. Experientia. 1977 May 15;33(5):575-7. PubMed PMID: 862771.
Angrist BM, Sathananthan G, Thompson H, Gershon S. A clinical trial of a structurally unique neuroleptic (SU-23397). Curr Ther Res Clin Exp. 1975 Aug;18(2):359-63. PubMed PMID: 809249.